New hope for kids with relapsed leukemia: experimental drug combo enters safety trial
NCT ID NCT06177067
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This early-stage study tests whether adding a new drug called revumenib to two standard chemotherapy drugs is safe for children and young adults whose acute myeloid leukemia (AML) has not responded to treatment or has returned. The study involves 24 participants and aims to find the best dose of the three-drug combination. The goal is to control the disease, not necessarily cure it, as ongoing management may still be needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Children's Healthcare of Atlanta
RECRUITINGAtlanta, Georgia, 30329, United States
-
Children's Hospital Colorado
RECRUITINGAurora, Colorado, 80045, United States
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Children's Mercy Hospital of Kansas City
RECRUITINGKansas City, Missouri, 64108, United States
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
-
Cook Children's Medical Center
RECRUITINGFort Worth, Texas, 76104, United States
-
Memorial Sloan- Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Rady Children's Hospital
RECRUITINGSan Diego, California, 92132, United States
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Email: •••••@•••••
-
UT Southwestern/Simmons Cancer Center
RECRUITINGDallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personalized chemo and transplants aim to beat infant leukemia
- New drug aims to wake up immune system against Hard-to-Treat leukemia
- New drug combo aims to outsmart resistant leukemia
- Gentler chemo approach shows promise for tough blood cancers in older patients
- New combo aims to wipe out hidden leukemia cells
- Selective immune cell removal may tame transplant complications